https://de.marketscreener.com/kurs/aktie/GSK-PLC-9590199/news/GSK-plc-gibt-positive-Ergebnisse-der-zulassungsrelevanten-Phase-III-Studie-Eagle-1-fur-Gepotidacin-46459226/?utm_source=telegram&utm_medium=social&utm_campaign=share